I. General Nursing Care
|
21%
|
|
A. Assess, Analyze, and Monitor the Patient's Health Status through Evidence Based Practice to Determine Necessary Nursing Interventions
|
|
Knowledge of:
|
|
|
|
1. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
2. Physiological, psychological, social, sexual, cultural, and spiritual aspects of patient wellness
|
|
|
|
3. Pharmacology (e.g., prescription medication, OTC, supplements/herbal, compliance/non-compliance issues, education, drug interaction)
|
|
|
|
4. Patients' rights and privacy (e.g., HIPAA, ethics)
|
|
|
|
5. Standards of clinical nursing practice and role delineation in gastroenterology setting
|
|
|
B. Develop a Plan of Care and Educate based on the Patient's Level of Understanding
|
|
|
Knowledge of:
|
|
|
|
1. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
2. Physiological, psychological, social, sexual, cultural, and spiritual aspects of patient wellness
|
|
|
|
3. Pharmacology (e.g., prescription medication, OTC, supplements/herbal, compliance/non-compliance issues, education, drug interaction)
|
|
|
|
4. Patients' rights and privacy (e.g., HIPAA, ethics)
|
|
II. Gastroenterological Procedures
|
35%
|
|
A. Collaborate with the Health Care Team during Endoscopic Procedures to Provide Safe Care
|
|
|
Knowledge of:
|
|
|
|
1. Endoscopic procedures (diagnostic and therapeutic)
|
|
|
|
2. Equipment, devices, and accessories
|
|
|
|
3. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
4. Environment of care (e.g., thermal burns, chemical spills, radiation, timeout)
|
|
|
|
5. Pharmacology (e.g., sedation/anesthesia medication, reversal agents, procedure medications, resuscitative medication)
|
|
|
|
6. Physiological, psychological, social, sexual, spiritual, and cultural aspects of wellness
|
|
|
|
7. Potential complications and anticipated interventions (e.g., hemorrhage, perforation, compromised airway, medication reaction)
|
|
|
|
8. Specimen preparation, collection, processing, and handling (e.g., labelling, storage, transportation, documentation)
|
|
|
B. Collaborate with the Health Care Team and Perform Non-Endoscopic Procedures to Provide Safe Care
|
|
|
Knowledge of:
|
|
|
|
1. Non-endoscopic procedures (e.g., diagnostic, therapeutic)
|
|
|
|
2. Equipment, devices, and accessories
|
|
|
|
3. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
4. Environment of care (e.g., time out, spills)
|
|
|
|
5. Pharmacology (e.g., learning needs, sedation/anesthesia medications, reversal agents, procedure medications, resuscitative medication, biologics)
|
|
|
|
6. Physiological, psychological, social, sexual, spiritual, and cultural aspects of wellness
|
|
|
|
7. Potential risks, complications, and interventions
|
|
|
|
8. Specimen preparation, collection, processing, and handling (e.g., labelling, storage, transportation, documentation)
|
|
III. Patient Care Interventions
|
25%
|
|
A. Recognize and Respond to Emergent Changes in Patient Status to Prevent Complications and Maximize Positive Outcomes
|
|
|
Knowledge of:
|
|
|
|
1. Potential risks, complications, and anticipated interventions (e.g., underlying conditions)
|
|
|
|
2. Resuscitation procedures and equipment
|
|
|
|
3. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
4. Emergency/reversal medications
|
|
|
|
5. Sedation/anesthesia guidelines and principles (e.g., American Society of Anesthesia [ASA], airway status)
|
|
|
B. Promote Wellness by Managing GI Health Care Needs
|
|
|
Knowledge of:
|
|
|
|
1. Health maintenance, health promotion, and disease prevention activities (e.g., diet, nutrition, screening intervals, adenoma detection rates [ADR], lifestyle modification)
|
|
|
2. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
3. Therapeutic interventions in pain management (e.g., ambulation, medication, positioning)
|
|
|
|
4. Patient's rights and responsibilities (e.g., advance directives)
|
|
|
|
5. Pharmacology (e.g., PPI, laxative, pro-biotics, biologics, timing of medication)
|
|
|
|
6. Potential complications (e.g., flare ups, drug reactions/interactions)
|
|
|
|
7. Physiological, psychological, social, sexual, spiritual, and cultural aspects of wellness
|
|
|
|
8. Resources (e.g., palliative, support group, financial and social assistance)
|
|
|
C. Administer Medications and Fluids to Provide Safe Care
|
|
|
Knowledge of:
|
|
|
|
1. Established standards for administering medications and fluids (e.g., safe administration practices)
|
|
|
|
2. Normal and abnormal gastrointestinal anatomy, physiology, and pathophysiology
|
|
|
|
3. Pharmacology (e.g., biologics, infusions/injections, antibiotic, timing of medication)
|
|
|
|
4. Physiological, psychological, social, sexual, cultural, and spiritual aspects of wellness
|
|
|
|
5. Potential adverse reactions, complications, and anticipated interventions
|
|
IV. Environmental Safety, Infection Prevention and Control
|
19%
|
|
A. Implement Procedure-Related Environmental Safety, Infection Prevention, and Control
|
|
|
Knowledge of:
|
|
|
|
1. Standards for infection prevention in an endoscopy setting (e.g., validation of competencies, OEM instructions for use, PPE, spills)
|
|
|
|
2. Equipment reprocessing (e.g., scopes, devices, and accessories, AER, bio burden, timing/delayed reprocessing)
|
|
|
|
3. Sterilization and high-level disinfection (e.g., Spaulding classification, single use devices versus reusable devices, minimal effective concentration of disinfection solutions)
|
|
|
4. Safe administration practices (e.g., multi-dose vial)
|
|
|
|
5. Body mechanics (e.g., ergonomics, abdominal pressure, repetitive injuries)
|
|
|
|
6. Electrical, laser, radiation, and chemical exposure (e.g., body piercings, tattoos, implanted devices, return electrode placement)
|
|
|
B. Implement Environmental Safety, Infection Prevention and Control in Gastroenterology
|
|
|
Knowledge of:
|
|
|
|
1. Patient education related to infectious disease
|
|
|
|
2. Pathogen transmission (e.g., bloodborne, airborne, contact)
|
|
|
|
3. Multi-drug resistant organisms (e.g., VRE, CRE)
|
|
|
|
4. Personal Protective Equipment (PPE)
|
|
|
|
5. Surface disinfection (e.g., point-of-care monitors, non-disposable equipment, communication devices, contact time)
|
|